Dec 20,2016

Samsung Ventures Invests in Noom, Inc. to Change Behaviors That Cause the Most Pressing Chronic Conditions

Noom, Inc., the world’s leading behavior change company, today announced an investment from Samsung Ventures. Noom’s platform combines human coaching and artificial intelligence to deliver successful, scalable behavior change programs that prevent and manage chronic conditions.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Jan 12,2017

DarioHealth raises $5.1M to expand markets for smart blood glucose monitoring system

Israel-based DarioHealth, makers of a smartphone-connected glucometer, has raised $3 million as part of a definitive agreement for a total aggregate raise of $5.1 million. Crowdfunding equity platform OurCrowd Qure led the investment round. The company, which has also done business as LabStyle, said it will use the funding to expand the company’s existing markets as well as move into new geographic areas.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Jan 31,2017

SidekickHealth maker Goodlifeme raises $1.5m round led by Frumtak Ventures

Frumtak Ventures just announced a $1.5m investment into Goodlifeme AB, maker of Sidekick Health. Other participants in the round include Tennin ehf. and other investors. “This investment gives our team of physicians, psychologists, public health professionals and game developers the opportunity to deepen SidekickHealth’s global reach, particularly in the United States,” said Tryggvi Thorgeirsson, co-founder and CEO of Goodlifeme.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Feb 09,2017

RecoveryOne raises $3.9 million

The document is a Form D filing submitted to the U.S. Securities and Exchange Commission (SEC) by RecoveryOne, a healthcare technology company that provides digital health solutions for addiction recovery. The purpose of the filing is to disclose that RecoveryOne has raised $3,859,534 in equity financing. The funds will be used to support the company's growth and expansion efforts.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Mar 01,2017

Medisafe raises $14.5M, announces European expansion

Medication adherence startup MediSafe has raised $14.5 million in a round led by Octopus Ventures and M Ventures (the venture arm of Merck Pharmaceuticals), with participation from existing investors Pitango Venture Capital, 7wire ventures, lool Ventures, TriVentures and Qualcomm Ventures. The company also announced that it will begin expanding into Europe using some of the funds.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Mar 08,2017

Virta Health Raises $37m in Funding

Virta Health, a San Francisco, CA-based company launched to reverse type 2 diabetes, raised $37m in funding. Backers included Venrock, Allen & Company, Ev Williams’ Obvious Ventures, Redmile Group, and PayPal and Affirm founder Max Levchin’s Scifi VC.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Mar 16,2017

Smart diabetes management service Livongo Health raises $52.5M and looks to new markets

Livongo Health has raised an additional $52.5 million in a round led by General Catalyst and Kinnevik. At the moment, Livongo Health is focused on diabetes management. But given that the company has been able to wedge itself into the budgets of payers and into the minds of consumers, it seems natural that it would treat it as a launch point. Tullman said the next step, in addition to trying to expand internationally, is to also grow into management for other chronic diseases.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
Apr 17,2017

Dthera Sciences Receives $1.2M Funding

Dthera Sciences received $1.2 million funding from the investors in an equity round according to the SEC form.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
May 31,2017

One Drop Secures $6M in Equity Round

The document is a Form D filing submitted to the US Securities and Exchange Commission by One Drop, a diabetes management platform. According to the filing, One Drop has raised $6,112,628 USD through the issuance of convertible promissory notes to an undisclosed group of investors. The notes are convertible into equity shares in the company at a later date. The funds will be used to support the company's growth and expansion efforts.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Jun 16,2017

Amalgam Rx raises $1.2M

The document is a Form D filing submitted to the US Securities and Exchange Commission by Amalgam Rx, a healthcare technology company. According to the filing, Amalgam Rx has raised $1,223,886 USD through the issuance of equity securities to an undisclosed group of investors. The funds raised will be used for working capital and general corporate purposes.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING